Vanguard Global Advisers »

Neumora Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $61k 31k 1.95

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Neumora Therapeutics

Softbank Group Corp
Siren
Perceptive Advisors
Vanguard Group
MIC Capital Management UK
Vanguard Capital Management
FMR
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Millennium Management
ICONIQ Capital
Lunate Capital
BlackRock
Two Sigma Investments
Johnson & Johnson
Renaissance Technologies

View all funds holding Neumora Therapeutics